Changqing Wei

This inventor holds 12 USPTO granted patents and 1 published patent application, plus 6 CIPO patents and 10 EPO patents. Top assignees: Medshine Discovery Inc., Zhuhai United Laboratories Co., Ltd., Cstone Pharmaceuticals. Active years: 2018-2025.

USPTO Granted Patents = 12 (Patent Applications = 1)

% Patents Active = 100.0

CIPO Patents = 6 (Patent Applications = 2)

EPO Patents = 10 (Patent Applications = 12)

Average Co-Inventor Count = 6.3

ph-index = 2

Forward Citations = 23(Granted Patents)

Company Filing History:

4 out of 71

Medshine Discovery Inc.

patents

3 out of 8

Zhuhai United Laboratories Co., Ltd.

patents

2 out of 9

Cstone Pharmaceuticals

patents

4. 2 out of 7

Cstone Pharmaceuticals (Shanghai) Co., Ltd.

patents

5. 2 out of 5

Cstone Pharmaceuticals (Suzhou) Co., Ltd.

patents

6. 1 out of 7

Cisen Pharmaceutical Co., Ltd.

patents

7. 1 out of 5

Guangdong Zhongsheng Pharmaceutical Co., Ltd

patents

8. 1 out of 4

Guangzhou Joyo Pharmatech Co., Ltd.

patents

9. 1 out of 5

Kpc Pharmaceuticals, Inc.

patents

where one patent can have more than one assignee

Years Active: 2018-2025

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12486266 - Crystalline form of JAK inhibitor and application thereof (2025-12-02),

2. 12428391 - Dimethylsulfoximine derivative (2025-09-30),

3. 12391653 - Salt form and crystal form of mutant IDH1 inhibitor and preparation method therefor (2025-08-19),

4. 12351590 - Pyrrolopyrimidine compound and use thereof (2025-07-08),

5. 11919896 - [1,2,4]triazolo[1,5-a]pyridine compound as JAK inhibitor and use thereof (2024-03-05),

6. 11634424 - Diazaindole derivative and use thereof as CHK1 inhibitor (2023-04-25),

7. 11427581 - JAK inhibitor and use thereof (2022-08-30),

8. 11345682 - Polymorph of HDAC6-selective inhibitor and application thereof (2022-05-31),

9. 11254666 - Compound as GLS1 inhibitor (2022-02-22),

10. 11230544 - Substituted 1,3,4-thiadiazoles as GLS1 inhibitors (2022-01-25),

11. 10745389 - HDAC6 selective inhibitors, preparation method therefor, and application thereof (2020-08-18),

12. 9938292 - Quinoline derivatives as SMO inhibitors (2018-04-10),

Title: Changqing Wei - Pioneering Inventor from Shanghai

Introduction: Changqing Wei is a distinguished inventor hailing from Shanghai, China, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Changqing Wei holds several patents in the areas of artificial intelligence, renewable energy, and advanced manufacturing processes, showcasing his versatility and ingenuity in various domains.

Career Highlights: With a career spanning over two decades, Changqing Wei has worked with leading tech companies in Shanghai, spearheading research and development projects that have led to significant technological advancements.

Collaborations: Throughout his career, Changqing Wei has collaborated with top research institutions and universities in China, fostering a culture of innovation and knowledge sharing within the industry.

Conclusion: Changqing Wei's relentless pursuit of innovation and his passion for pushing the boundaries of technology make him a true visionary in the world of inventions.